«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

23卷

期数:

2017年02期

页码:

148-150

栏目:

临床医学

出版日期:

2017-03-20

文章信息/Info

Title:

Expression and diagnostic value of biliary carcinoembryonic antigen-related cellular adhesion molecule 6 in Cholangiocarcinoma

文章编号:

1006-8147(2017)02-0148-03

作者:

陈 莹¹; 2;  张雅敏³

(1.天津医科大学一中心临床学院肝胆外科，天津 300192; 2.天津市职业病防治院外科, 天津300011;3.天津市第一中心医院肝胆外科, 天津300192)

Author(s):

CHENYing¹; 2; ZHANGYa-min³

(1. Department of Hepatobiliary Surgery,The First Center Clinical College, Tianjin Medical University,Tianjin 300192,China; 2. Department of Surgery, Tianjin Occupational Diseases Precaution and Therapeutic Hospital, Tianjin 300011,China; 3.Department of Hepatobiliary Surgery,Tianjin First Center Hospital， Tianjin 300192,China)

关键词:

癌胚抗原相关细胞黏附分子6; 胆管癌; 诊断

Keywords:

carcinoembryonic antigen-related cellular adhesion molecule 6;  biliary cancer; diagnose

分类号:

R73

DOI:

-

文献标志码:

A

摘要:

目的：检测胆管癌患者胆汁中癌胚抗原相关细胞黏附分子6（CEACAM6）的水平并判断其对胆管癌的诊断价值。方法：选取因胆管梗阻行手术治疗的患者63例，根据术后病理结果分为良性组（n=32）和胆管癌组（n=31）。于术中留取患者胆汁，应用ELISA法测定CEACAM6水平。应用Wilcoxon Rank Sum、线性回归、多元回归以及受试者工作特征曲线（ROC）评估CEACAM6对胆管癌的诊断价值。结果：与胆管癌组相比，良性组患者年龄更小，女性比例更高，CEACAM6水平更低（8.5 ng/mLvs.39ng/mL，P≤0.001）。ROC曲线显示，当CEACAM6水平大于14 ng/mL时，其诊断胆管癌的敏感性为87.5%，特异性为69.1%。多元回归分析显示，碱性磷酸酶（ALP）和支架数与CEACAM6相关。结论：胆管癌患者CEACAM6水平升高，且可作为胆管癌的诊断指标。

Abstract:

Objective ：To detect the level of CEACAM6 in the bile of patients with biliary cancer and to explore）its diagnostic value for cholangiocarcinoma.Methods: Sixty-three patients were enrolled in this study and were divided into cholangiocarcinoma group（n=32） and benign group（n=31）.Bilewas collected during operation. The concentration of CEACAM6 was quantified by sandwich enzyme-linked immunosorbent assay (ELISA) and correlated with pathologic diagnosis. Diagnostic capability of CEACAM6 was evaluated by Wilcoxon rank-sum, linear regression, multiple regression, and receiver operating characteristic (ROC) curve analysis.Results：Patients in the benign group were younger, predominantly female, and had lower median biliary CEACAM6 levels than patients in the cholangiocarcinoma group (8.5 ng/mLvs. 39 ng/mL; P≤0.001). ROC curve analysis determined CEACAM6 to be a positive predictor and a CEACAM6 level >14 ng/mL was associated with 87.5% sensitivity, and69.1% specificity. Multiple regression analysis suggested elevated alkaline phosphatase and the presence of biliary endoprosthesesmayinfluence CEACAM6 levels. Conclusion: Biliary CEACAM6 level may increase in patients with cholangiocarcinoma and can identify cholangiocarcinoma.

参考文献/References:

[1] Ebata T, Ercolani G, Alvaro D, et al. Current status on cholangiocarcinoma and gallbladder cancer[J]. Liver Cancer, 2016,6(1):59

[2]Alvaro D S. Bile biomarkers for cholangiocarcinoma[J].CurrOpin Gastroenterol,2009，25(3):279

[3]刘强,卢茂松,张天华,等.胆管癌患者血清肿瘤标记物糖类抗原19-9的动态变化及其临床意义 [J].中国老年杂志，2012,32(17):3694

[4]Bangarulingam S Y, Bjornsson E, Enders F A, et al. Long-Term outcomes of positive fluorescence in situ hybridization tests in primary sclerosingcholangitis[J].Hepatology,2010,51(1):174

[5] Farina A, Dumonceau J M, Antinori P, et al. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses[J].Biochim Biophys Acta，2014 , 1844(5):1018

[6]Ho T H, Serie D J, Parasramka M, et al. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes[J]. Ann Oncol， 2016， [Epub ahead of print]
[7] Alvaro D, Macarri G, Mancino M. Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis[J]. Ann Intern Med， 2007，147(7): 451

[8]Gebauer F, Wicklein D, Horst J, et al. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers inpancreatic cancer[J].PLoS One, 2014, 9(11):e113023

[9]Patel T. Cholangiocarcinoma-controversies and challenges[J].Nat Rev Gastroenterol Hepatol,2011,8(4):189

相似文献/References:

备注/Memo

备注/Memo:

作者简介? 陈莹（1981-），男，主治医师,硕士，研究方向：肝胆外科；通信作者：张雅敏，E-mail：zhangyamin@medmail.com.cn。